Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets

Drug Development and Industrial Pharmacy

Volumn 31, Issue 4-5, 2005, Pages 385-395

  Alsarra, Ibrahim A ^a   El Bagory, Ibrahim ^a   Bayomi, Mohsen A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Chitosan; Prolonged release tablets; Sodium sulfate; Theophylline; Wet granulation

Indexed keywords

CHITOSAN; GUAIFYLLINE; SODIUM SULFATE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG GRANULATION; HARDNESS; IN VIVO STUDY; MALE; NONHUMAN; POROSITY; SUSTAINED RELEASE PREPARATION; TABLET FORMULATION; TENSILE STRENGTH;

ANIMALS; AREA UNDER CURVE; CHITOSAN; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOGS; DRUG STABILITY; EXCIPIENTS; HARDNESS; INTUBATION, INTRATRACHEAL; MALE; MOLECULAR WEIGHT; PARTICLE SIZE; SOLUBILITY; SULFATES; TABLETS; TECHNOLOGY, PHARMACEUTICAL; TENSILE STRENGTH; THEOPHYLLINE; VASODILATOR AGENTS;

EID: 24744450543     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500214563     Document Type: Article

References (24)

1. Acarturk, F. (1989). Preparation of a prolonged-release tablet formulation of diclofenac sodium. 1. Using chitosan. Pharmazie, 44, 547-549.
2. Al-Angary, A. A., Khidr, S. H., Mahrous, G. M., & Gouda, M. W. (1990). In-vitro dissolution and in-vivo absorption of marketed sustained release theophylline preparations. International Journal of Pharmaceutics, 65, R5-R8.
3. Banker, G. S., & Anderson, N. R. (1986). Tablets. In: L. Lachman, H. A. Liberman, & J. L. Kanig (Eds.), The Theory and Practice of Industrial Pharmacy (pp. 293-345). Philadelphia: Lea and Febiger.
4. Bayomi, M. A. (2003). Influence of polymers weight ratio and pH of polymers solution on the characteristics of chitosan-carboxymethyl cellulose microspheres containing theophylline. Bollettino Chimico Farmaceutico, 142, 336-342.
5. Bayomi, M. A., Al-Suwayeh, S. A., & El-Helw, A. R. (2001). Excipient-excipient interaction in the design of sustained-reiease theophylline tablets: in vitro and in vivo evaluation. Drug Development and Industrial Pharmacy, 27, 499-506.
6. Berger, J., Reist, M., Mayer, J. M., Felt, O., Peppas, N. A., & Gurny, R. (2004). Structure and interactions in covaiently and ionically crosslinked chitosan hydrogels for biomedical applications. European Journal of Pharmaceutics and Biopharmaceutics, 57, 19-34.
7. Bernkop-Schnurch, A., Schuhbauer, H., Clausen, A. E., & Hanel, R. (2004). Development of a sustained release dosage form for alpha-lip acid. I. Design and in vitro evaluation. Drug Development and Industrial Pharmacy, 30, 27-34.
8. Hejazi, R., & Amiji, N. (2003). Stomach-specific anti-H. pylori therapy. II. Gastric residence studies of tetracycline-loaded chitosan microspheres in gerbil. Pharmaceutical Development and Technology, 8, 253-262.
9. Hirano, S., Ohe, Y., & One, H. (1976). Selective N-acetylation of chitosan. Carbohydrate Research, 47, 315-320.
10. Illum, L. (1998). Chitosan and its uses as a pharmaceutical excipient. Pharmaceutical Research, 15, 1326-1331.
11. Jacobs, M. H., Senior, R. M., & Kessler, G. (1976). Clinical experience with theophylline. Relationships between dosage, serum concentration, and toxicity. JAMA, 235, 1983-1986.
12. Jain, S. K., Chourasia, M. K., Sabitha, M., Jain, R., Jain, R., Jain, A. K., Ashawat, M., & Jha, A. K. (2003). Development and characterization of transdermal drug delivery systems for diltiazem hydrochloride. Drug Delivery, 10, 169-177.
13. Lacey, L. F., Keene, O. N., Duquesnoy, C., & Bye, A. (1994). Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies. Journal of Pharmaceutical Sciences, 83, 212-215.
14. Miyazaki, S., Nakayama, A., Oda, M., Takada, M., & Atwood, D. (1994). Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. Biological and Pharmaceutical Bulletin, 17, 745-747.
15. Mura, P., Zerrouk, N., Mennini, N., Maestrelli, F., & Chemtob, C. (2003). Development and characterization of naproxen-chitosan solid system with improved drug dissolution properties. European Journal of Pharmaceutical Sciences, 19, 67-75.
16. Niaga, T., Sawayanagi, Y., & Nambu, N. (1984). Application of chitin and chitosan to pharmaceutical preparations. In: J. P. Zikakis (Ed.), Chitin, Chitosan and Related Enzymes (pp. 21-40). New York: Academic Press, Inc.
17. Ozbas-Turan, S., Akbuga, J., & Aral, C. (2002). Controlled release of interleukin-2 from chitosan microspheres. Journal of Pharmaceutical Sciences, 91, 1245-1251.
18. Roldo, M., Hornof, M., Caliceti, P., & Bernkop-Schnurch, A. (2004). Mucoadhesive thiolated chitosan as platforms for oral controlled drug delivery: synthesis and ion vitro evaluation. European Journal of Pharmaceutics and Biopharmaceutics, 57, 115-121.
19. Sabnis, S., Rege, P., & Block, L. H. (1997). Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. Pharmaceutical Development and Technology, 2, 243-255.
20. Sawayanagi, Y., Nambu, N., & Nagi, T. (1982). Directly compressed tablets containing chitin or chitosan in addition to manitol. Chemical and Pharmaceutical Bulletin, 30, 4216.
21. Sinha, V. R., & Kumria, R. (2002). Binders for colon specific drug delivery: an in vitro evaluation. International Journal of Pharmaceutics, 249, 23-31.
22. Skaugrud, O., Hagen, A., Borgersen, B., & Dornish, M. (1999). Biomedical and pharmaceutical applications of alginate and chitosan. Biotechnology and Genetic Engineering Reviews, 16, 23-40.
23. Tapia, C., Costa, E., Terraza, C., Munita, A. M., & Azdani-Pedram, M. (2002). Study of the prolonged release of theophylline from polymeric matrices based on grafted chitosan with acrylamide. Pharmazie, 57, 744-749.
24. Upadrashta, S., Katikaneni, P., & Nuessle, N. (1992). Chitosan as a tablet binder. Drug Development and Industrial Pharmacy, 15, 1701-1708.